These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 21215744

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.
    Marti M, Trapella C, Morari M.
    J Neurochem; 2008 Dec; 107(6):1683-96. PubMed ID: 19014386
    [Abstract] [Full Text] [Related]

  • 3. The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
    Mabrouk OS, Marti M, Salvadori S, Morari M.
    Neuroscience; 2009 Dec 01; 164(2):360-9. PubMed ID: 19729051
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
    Mabrouk OS, Marti M, Morari M.
    Neuroscience; 2010 Mar 10; 166(1):40-8. PubMed ID: 20006677
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
    Viaro R, Calcagno M, Marti M, Borrelli E, Morari M.
    Neuropharmacology; 2013 Sep 10; 72():126-38. PubMed ID: 23643745
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M, Mela F, Veronesi C, Guerrini R, Salvadori S, Federici M, Mercuri NB, Rizzi A, Franchi G, Beani L, Bianchi C, Morari M.
    J Neurosci; 2004 Jul 28; 24(30):6659-66. PubMed ID: 15282268
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NOP Receptor Ligands and Parkinson's Disease.
    Mercatelli D, Pisanò CA, Novello S, Morari M.
    Handb Exp Pharmacol; 2019 Jul 28; 254():213-232. PubMed ID: 30689087
    [Abstract] [Full Text] [Related]

  • 12. Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release.
    Marti M, Mela F, Guerrini R, Calò G, Bianchi C, Morari M.
    J Neurochem; 2004 Dec 28; 91(6):1501-4. PubMed ID: 15584926
    [Abstract] [Full Text] [Related]

  • 13. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
    Marti M, Mela F, Bianchi C, Beani L, Morari M.
    J Neurochem; 2002 Nov 28; 83(3):635-44. PubMed ID: 12390525
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonism.
    Mabrouk OS, Volta M, Marti M, Morari M.
    J Neurochem; 2008 Dec 28; 107(6):1647-59. PubMed ID: 19094058
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.
    Marti M, Guerrini R, Beani L, Bianchi C, Morari M.
    Neuroscience; 2002 Dec 28; 112(1):153-60. PubMed ID: 12044480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.
    Marti M, Mela F, Fantin M, Zucchini S, Brown JM, Witta J, Di Benedetto M, Buzas B, Reinscheid RK, Salvadori S, Guerrini R, Romualdi P, Candeletti S, Simonato M, Cox BM, Morari M.
    J Neurosci; 2005 Oct 19; 25(42):9591-601. PubMed ID: 16237164
    [Abstract] [Full Text] [Related]

  • 19. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain.
    Ferraro L, Tomasini MC, Fernandez M, Bebe BW, O'Connor WT, Fuxe K, Glennon JC, Tanganelli S, Antonelli T.
    Neuroscience; 2001 Oct 19; 102(1):113-20. PubMed ID: 11226674
    [Abstract] [Full Text] [Related]

  • 20. Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.
    Marti M, Rodi D, Li Q, Guerrini R, Fasano S, Morella I, Tozzi A, Brambilla R, Calabresi P, Simonato M, Bezard E, Morari M.
    J Neurosci; 2012 Nov 14; 32(46):16106-19. PubMed ID: 23152595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.